Cetyl Myristoleate (CMO) vs Diosmin + Hesperidin

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Cetyl Myristoleate (CMO)Diosmin + Hesperidin
CategorySupplementsSupplements
Standard Dose
Timing
Cycle Duration
Evidence LevelLimited-ModerateStrong (venous insufficiency — prescription in EU)

Mechanism

Fatty acid ester with anti-inflammatory and joint-lubricating properties. Modulates immune response by inhibiting 5-lipoxygenase and modulating prostaglandin synthesis. Reduces joint inflammation and improves range of motion in arthritic conditions.

Contraindications

  • Severe liver disease

Mechanism

Micronized flavonoid fraction that strengthens venous tone, reduces capillary permeability, and improves lymphatic drainage. Inhibits prostaglandin and thromboxane synthesis. Used as prescription venotonic in Europe for chronic venous insufficiency and hemorrhoids.

Contraindications

  • None established at standard doses

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →